Skip to main content

Effects of Neoadjuvant Therapy on Perioperative Morbidity in Elderly Patients Undergoing Esophagectomy for Esophageal Cancer

Abstract

Background

The use of cytoreductive therapy followed by surgery is preferred by many centers dealing with locally advanced esophageal cancer. However, the potential for increase in mortality and morbidity rates has raised concerns on the use of chemoradiation therapy, especially in elderly patients. The aim of this study was to assess the effects of induction therapy on postoperative mortality and morbidity in elderly patients undergoing esophagectomy for locally advanced esophageal cancer at a single institution.

Methods

Postoperative mortality and morbidity of patients ≥70 years old undergoing esophagectomy after neoadjuvant therapy, between January 1992 and October 2005 for cancer of the esophagus or esophagogastric junction, were compared with findings in younger patients also receiving preoperative cytoreductive treatments.

Results

818 patients underwent esophagectomy during the study period. The study population included 238 patients <70 years and 31 ≥70 years old undergoing esophageal resection after neoadjuvant treatment. Despite a significant difference in comorbidities (pulmonary, cardiological and vascular), postoperative mortality and morbidity were similar irrespective of age.

Conclusions

Elderly patients receiving neoadjuvant therapies for cancer of the esophagus or esophagogastric junction do not have a significantly increased prevalence of mortality and major postoperative complications, although cardiovascular complications are more likely to occur. Advanced age should no longer be considered a contraindication to preoperative chemoradiation therapy preceding esophageal resection in carefully selected fit patients.

This is a preview of subscription content, access via your institution.

FIG. 1.

References

  1. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462–7

    PubMed  Article  CAS  Google Scholar 

  2. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;161–7

  3. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979–84

    PubMed  Article  CAS  Google Scholar 

  4. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 2002;359:1727–33

    Article  Google Scholar 

  5. Burmeister B, Smithers B, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the esophagus: a randomized controlled phase III trial. Lancet Oncol 2005;6:659–68

    PubMed  Article  Google Scholar 

  6. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305–13

    PubMed  CAS  Google Scholar 

  7. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003;185:538–43

    PubMed  Article  Google Scholar 

  8. Kaklamanos IG, Walker GR, Ferri K, et al. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003;10:754–61

    PubMed  Article  Google Scholar 

  9. Malthaner RA, Collin S, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev. 2006;19:3:CD001556

    Google Scholar 

  10. Ancona E, Ruol A, Santi S, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001;91:2165–74

    PubMed  Article  CAS  Google Scholar 

  11. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049–53

    PubMed  Article  CAS  Google Scholar 

  12. Hutchins LF, Unger J, Crowley J, et al. Underreppresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341:2061–67

    PubMed  Article  CAS  Google Scholar 

  13. Lin FC, Durkin AE, Ferguson MK. Induction therapy does not increase surgical morbidity after esophagectomy for cancer. Ann Thoracic Surg 2004;78:1783–89

    Article  Google Scholar 

  14. Kelly ST, Coppola D, Karl RC. Neoadjuvant chemotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gastrointest Surg 2004;8:227–32

    Article  Google Scholar 

  15. Rice DC, Correa AM, Vaporciyan AA, et al. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thoracic Surg 2005;79:391–7

    Article  Google Scholar 

  16. Ruol A, Portale G, Zaninotto G, et al. Age does not affect outcome and survival after esophagectomy for esophageal cancer. J Thorac Cardiovasc Surg 2007;133:1186–1192

    Google Scholar 

  17. Ferguson MK, Martin TR, Reeder LB, et al. Mortality after esophagectomy: risk factor analysis. World J Surg 1997;21:599–604

    PubMed  Article  CAS  Google Scholar 

  18. Rahamin JS, Murphy GJ, Awan Y, et al. The effect of age on the outcome of surgical treatment for carcinoma of the oesophagus and gastric cardia. Eur J Cardiothorac Surg 2003;23:805–10

    Article  Google Scholar 

  19. Merigliano S, Ruol A, Baldan N, et al. Management and prognosis of esophageal cancer in elderly patients. J Chemotherapy 1996;8:72–4

    Google Scholar 

  20. Naunheim KS, Hanosh J, Zwischenberger J, et al. Esophagectomy in the septuagenarian. Ann Thorac Surg 1993;56:880–4

    PubMed  CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Carlo Castoro MD, FACS.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ruol, A., Portale, G., Castoro, C. et al. Effects of Neoadjuvant Therapy on Perioperative Morbidity in Elderly Patients Undergoing Esophagectomy for Esophageal Cancer. Ann Surg Oncol 14, 3243–3250 (2007). https://doi.org/10.1245/s10434-007-9455-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9455-z

Keywords

  • Esophageal cancer
  • Esophagectomy
  • Neoadjuvant therapy
  • Elderly patients
  • Morbidity
  • Mortality
  • Survival